Study Finds Limited Kidney Benefit from More Rigorous Blood Pressure Treatment

November 18, 2014 2:25 PM

2 0

Washington DC - infoZine - Using two drugs was no more effective than a single drug in slowing disease progression in people with autosomal dominant polycystic kidney disease (ADPKD), according to two studies funded by the National Institutes of Health (NIH). One of the studies also showed that rigorous blood pressure treatment slowed growth of kidney cysts, a marker of ADPKD, but had little effect on kidney function compared to standard blood pressure treatment.

"Enlarged cysts in kidneys can lead to reduced kidney function and eventually kidney failure, where the only treatment is dialysis or transplantation," said study author Michael Flessner, M.D., Ph.D., a program director at the NIH's National Institute of Diabetes and Digestive and Kidney Diseases, w...

Also read: BRIEF-Draegerwerk sees FY net sales growth at lower end of forecast range

Read more

To category page